Brief: ISR Vaccine Enters Into MoU With Revitalife Holding Limited

ISR Immune System Regulation Holding AB (publ)

17/12/2021 12:33

Dec 17 (Reuters) - ISR Immune System Regulation Holding AB
(publ)  ISR.ST :
    * ISR VACCINE AB HAS ENTERED INTO AN AGREEMENT MOU WITH
REVITALIFE
HOLDING LIMITED FOR THE PRODUCTION AND SALE OF OUR INHALATION
VACCINE FOR SARS-COV2.
    * THE MOU REFERS TO THE "FILL AND SEAL" OF ISR'S VACCINE
WITH
LICENSING RIGHTS FOR PRODUCTION AND SALES IN THE MIDDLE EAST AND
NORTH AFRICA (MENA) WITH AN ANNUAL CAPACITY OF AT LEAST 200
MILLION DOSES.

Source text for Eikon:  ID:nWkr6D1xdj 
Further company coverage:  ISR.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))